Hydrochloric Acid

Hydrochloric Acid

SCHEMBL5065617

CCOc1cc(CN)ccc1O.Cl

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLA known ✓ P06280 1/20 0.53
GAA known ✓ P10253 3/20 0.49
TOP2A known ✓ P11388 1/20 0.45
ABL1 known ✓ P00519 1/20 0.44
BCR known ✓ P11274 1/20 0.44
ADRA2A known ✓ P08913 1/20 0.43
DRD2 known ✓ P14416 1/20 0.43
DRD1 known ✓ P21728 1/20 0.43
DRD4 known ✓ P21917 1/20 0.43
SLC6A2 known ✓ P23975 1/20 0.43
DRD3 known ✓ P35462 1/20 0.43
SLC6A3 known ✓ Q01959 1/20 0.43
LMNA P02545 4/20 0.53
TAAR1 Q96RJ0 2/20 0.53
ALDH1A1 P00352 5/20 0.52
TSHR P16473 3/20 0.52
KDM4E B2RXH2 3/20 0.52
KMT2A Q03164 5/20 0.50
MEN1 O00255 4/20 0.50
MAPK1 P28482 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1031519 0.98 ALDH1A1 (0.54) LMNATAAR1GLAALDH1A1TSHR
SCHEMBL12788915 0.86 TSHR (0.69) LMNATAAR1GLAALDH1A1TSHR
SCHEMBL27750597 0.84 CSNK2A1 (0.61) LMNATAAR1GLAALDH1A1TSHR
SCHEMBL14764675 0.84 CYP1A2 (0.50) LMNAALDH1A1TSHRKMT2AMEN1
Hydrochloric Acid SCHEMBL19921593 0.83 ALDH1A1 (0.48) LMNATAAR1GLAALDH1A1TSHR
SCHEMBL10762625 0.83 TRPA1 (0.57) TAAR1ALDH1A1TSHRKDM4EKMT2A
SCHEMBL27657253 0.82 TSHR (0.50) LMNATAAR1GLAALDH1A1TSHR
SCHEMBL31412813 0.81 ALDH1A1 (0.55) TAAR1ALDH1A1TSHRKDM4EKMT2A
SCHEMBL586875 0.81 ALDH1A1 (0.55) TAAR1ALDH1A1TSHRKDM4EKMT2A
Hydrochloric Acid SCHEMBL1143187 0.81 TAAR1 (0.77) LMNATAAR1GLAALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115819255-A Synthesis method of capsaicin substance 湖北航天化学技术研究所 2023-03-21 CN disclosed
CN-102417462-A Preparation method of 4-hydroxy-3-ethoxybenzylamine hydrochloride SHANGHAI HUAYI GROUP CO 2012-04-18 CN disclosed
CN-102417462-A Preparation method of 4-hydroxy-3-ethoxybenzylamine hydrochloride SHANGHAI HUAYI GROUP CO 2012-04-18 CN disclosed
US-20080214675-A1 Hydroxybenzoic Acid Amides and the Use Thereof For Masking Bitter Taste SYMRISE GMBH & CO. KG (DE) 2008-09-04 US disclosed
EP-1784088-A1 HYDROXYBENZOIC ACID AMIDES AND THE USE THEREOF FOR MASKING BITTER TASTE Symrise GmbH & Co. KG (DE) 2007-05-16 EP disclosed
WO-2006024587-A1 HYDROXYBENZOIC ACID AMIDES AND THE USE THEREOF FOR MASKING BITTER TASTE SYMRISE GMBH & CO. KG (DE) 2006-03-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214675-A1 Hydroxybenzoic Acid Amides and the Use Thereof For Masking Bitter Taste TAS1R1, TAS2R1, TAS1R2 GLA 3185/4885GAA 1606/4885TOP2A 4533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.